Melissa Thomas
Adult Health · Canton, OHNPI 1558751453
Payments from drug & device makers
Across 160 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$631
- Bayer$405
- Lilly USA, LLC$343
- Amgen$139
- AstraZeneca$138
- Novartis$113
- plus $1K from 29 others
What the payments were for
- Food & beverage$3,00799%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 42 | $631 |
| Bayer | 13 | $405 |
| Lilly USA, LLC | 19 | $343 |
| Amgen | 7 | $139 |
| AstraZeneca(2 entities) | 6 | $138 |
| Novartis | 7 | $113 |
| Corcept Therapeutics | 4 | $110 |
| Radius Health, Inc. | 5 | $109 |
| Xeris Pharmaceuticals, Inc. | 6 | $107 |
| Medtronic | 4 | $88 |
| Sanofi-aventis U.S. LLC | 4 | $82 |
| Dexcom, Inc. | 4 | $81 |
| Boehringer Ingelheim | 4 | $63 |
| Abbott | 4 | $56 |
| Insulet Corporation | 3 | $48 |
| Amryt Pharma Holdings Ltd | 3 | $47 |
| BETA Bionics, Inc. | 2 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Pfizer | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Amneal Pharmaceuticals LLC | 2 | $32 |
| Ultragenyx Pharmaceutical Inc. | 1 | $28 |
| Ascensia Diabetes Care US Inc. | 2 | $27 |
| Sequel Med Tech, LLC | 1 | $25 |
| AbbVie | 1 | $25 |
| OPKO Pharmaceuticals, LLC | 1 | $24 |
| Avvisto Therapeutics, LLC | 1 | $24 |
| Averitas Pharma Inc. | 1 | $23 |
| Ascendis Pharma Endocrinology Inc | 1 | $22 |
| Ionis Pharmaceuticals, Inc. | 1 | $19 |
| Recordati_rare_diseases_inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Tolmar, Inc. | 1 | $14 |
| Tandem Diabetes Care, Inc. | 1 | $14 |
| Cequr Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,032 in reported general payments places this provider in the 85th percentile of 1,184 adult health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 284 | $342,809 |
| JardianceEmpagliflozin | 283 | $252,281 |
| Tresiba Flextouch U-200Insulin Degludec | 132 | $142,768 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 77 | $123,036 |
| MounjaroTirzepatide | 88 | $104,931 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 43 | $102,550 |
| TrulicityDulaglutide | 67 | $72,394 |
| FarxigaDapagliflozin Propanediol | 91 | $69,824 |
| Tresiba Flextouch U-100Insulin Degludec | 74 | $66,153 |
| Humalog Kwikpen U-100Insulin Lispro | 164 | $52,410 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 44 | $52,039 |
| JanuviaSitagliptin Phosphate | 51 | $49,590 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 45 | $43,107 |
| Novolog FlexpenInsulin Aspart | 132 | $40,200 |
| TymlosAbaloparatide | 13 | $39,312 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $631 | $362,914306 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta | $63 | $332,726373 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $343 | $184,616185 claims |
| AstraZenecaFarxiga | $138 | $69,82491 claims |
| Radius Health, Inc.Tymlos | $109 | $39,31213 claims |
| BayerKerendia | $405 | $28,99639 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $32 | $8,349988 claims |
| AbbVieSynthroid | $25 | $7,642162 claims |
| Sanofi-aventis U.S. LLCLantus | $82 | $3,68521 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,184 adult health providers in Ohio.
Other adult health in Canton
- Bonnie MohlerCanton$338K
- Courtney Ray-MartyCanton$16K
- Kristen BurockCanton$8K
- Andrew GuinigundoCincinnati$215K
- Gabriella McCartyWestlake$177K
- Karen SteffeyLyndhurst$145K
- Marie ChambersCenterville$134K
- Susan FlickCleveland$131K
- Margaret TiktinCleveland$105K
- Teresa ShafferBoardman$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.